Neuphoria Therapeutics, Inc. (NEUP)
3.06
-0.30
(-8.93%)
USD |
NASDAQ |
Oct 29, 16:00
3.10
+0.04
(+1.31%)
After-Hours: 06:32
Neuphoria Therapeutics EPS Diluted (Quarterly) : -0.9063 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.9063 |
| March 31, 2026 | -0.0933 |
| December 31, 2025 | -0.7749 |
| September 30, 2025 | -4.411 |
| March 31, 2025 | 6.551 |
| Date | Value |
|---|---|
| December 31, 2024 | -1.234 |
| September 30, 2024 | -0.0035 |
| June 30, 2024 | -29.21 |
| March 31, 2024 | -33.98 |
| December 31, 2023 | -63.75 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.904M |
| Revenue (Quarterly) | 1.174M |
| Total Expenses (Quarterly) | 6.079M |
| Enterprise Value | -3.273M |
| Gross Profit Margin (Quarterly) | 85.89% |
| Profit Margin (Quarterly) | -417.7% |
| Earnings Yield | -202.1% |
| Normalized Earnings Yield | -159.57 |